Exodus Point Capital Management, LP Apellis Pharmaceuticals, Inc. Call Options Transaction History
Exodus Point Capital Management, LP
- $14.6 Billion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding APLS
# of Institutions
299Shares Held
111MCall Options Held
2.63MPut Options Held
845K-
Avoro Capital Advisors LLC New York, NY12.2MShares$222 Million5.68% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.9MShares$216 Million17.73% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$183 Million0.01% of portfolio
-
Morgan Stanley New York, NY9.63MShares$175 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.8MShares$105 Million0.01% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $2B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...